T/NK-cell
Showing 9976 - 10000 of >10,000
Hematopoietic Stem Cell Transplant Trial in Cincinnati (12-16 hour nutrition)
Active, not recruiting
- Hematopoietic Stem Cell Transplant
- 12-16 hour nutrition
-
Cincinnati, OhioCincinnati Children's Hospital
Oct 14, 2022
Plasmodium Falciparum Trial run by the (NMRC-M3V-Ad-PfCA, NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA)
Completed
- Plasmodium Falciparum
- NMRC-M3V-Ad-PfCA
- NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA
-
Bethesda, MarylandNaval Medical Research Center (NMRC) Clinical Trials Center
Apr 28, 2021
NSCLC NSCLC Trial in Worldwide (Durvalumab, Placebo for Olaparib, Olaparib)
Active, not recruiting
- Non-small Cell Lung Cancer NSCLC
- Durvalumab
- +7 more
-
Bonita Springs, Florida
- +67 more
Nov 15, 2022
Diffuse Large B Cell Lymphoma Trial in Shanghai (zanubrutinib)
Recruiting
- Diffuse Large B Cell Lymphoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 13, 2022
Infertility, Female, of Uterine Origin, Endometrial Fibrosis Trial in Nanjing (CBD-bFGF, Collagen/BMMNCs, Estrogen)
Recruiting
- Infertility, Female, of Uterine Origin
- Endometrial Fibrosis
- CBD-bFGF
- +2 more
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital
Sep 27, 2022
Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in
Completed
- Refractory Chronic Lymphocytic Leukemia
- +4 more
- Dasatinib
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 15, 2021
Metastatic Renal Cell Carcinoma Trial in Milan (Cabometyx)
Completed
- Metastatic Renal Cell Carcinoma
-
Milan, ItalyFondazione IRCCS Istituto Nazionale Tumori
Apr 23, 2021
Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])
Completed
- Gastric Cancer
- +2 more
- Ramucirumab Injection
- Ramucirumab Injection [Cyramza]
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023
Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Chronic Lymphocytic Leukemia
-
Stony Brook, New York
- +27 more
Aug 11, 2022
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Young TIL
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Stroke Trial (Chin tuck against resistance exercise)
Not yet recruiting
- Stroke
- Chin tuck against resistance exercise
- (no location specified)
Aug 25, 2023
NSCLC Trial in NanCHang (V9, )
Recruiting
- Non-small Cell Lung Cancer
- V9
- placebo
-
NanCHang, Jiang XI, ChinaChunling Jiang
Oct 17, 2021
Histiocytosis Trial in Beijing (68Ga-FAPI)
Not yet recruiting
- Histiocytosis
- 68Ga-FAPI
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Mar 25, 2023
Specific Protein Overexpression in Adult Non-Small Cell Lung
Not yet recruiting
- Non Small Cell Lung Cancer
- (no location specified)
Sep 29, 2023
Thromboembolism of Vein VTE in Colorectal Cancer, Thromboembolism of Vein in Pancreatic Cancer, Thromboembolism of Vein in NSCLC
Completed
- Thromboembolism of Vein VTE in Colorectal Cancer
- +2 more
-
Los Angeles, California
- +10 more
Feb 11, 2021
Squamous Cell Carcinoma of Head and Neck Trial in Italy (Nivolumab 240 MG in 24 ML Injection)
Completed
- Squamous Cell Carcinoma of Head and Neck
- Nivolumab 240 MG in 24 ML Injection
-
Bergamo, Italy
- +22 more
Apr 4, 2023
Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis Trial in Chicago (CNP-106, Placebo)
Not yet recruiting
- Myasthenia Gravis
- +3 more
- CNP-106
- Placebo
-
Chicago, IllinoisResearch Site
Oct 30, 2023
NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))
Completed
- Non-small Cell Lung Cancer
- Pembrolizumab
- Radiotherapy (SABR)
-
Melbourne, Victoria, Australia
- +1 more
May 23, 2022
Lymphoma, B-Cell, Chronic Lymphocytic Leukemia Trial in United States (FT596, Cyclophosphamide, Fludarabine)
Recruiting
- Lymphoma, B-Cell
- Chronic Lymphocytic Leukemia
- FT596
- +4 more
-
Chicago, Illinois
- +8 more
Jun 21, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Bortezomib, Metformin Hydrochloride,
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +2 more
-
Jacksonville, Florida
- +1 more
Jan 5, 2023
Retinitis Pigmentosa, Stem Cell Transplant Trial in Istanbul (Stem cell implantation)
Completed
- Retinitis Pigmentosa
- Stem Cell Transplant
- Stem cell implantation
-
Istanbul, TurkeyAcıbadem University
Jan 25, 2023
Interstitial Lung Disease, Surfactant Dysfunction Trial in Shanghai (Hydroxychloroquine)
Not yet recruiting
- Interstitial Lung Disease
- Surfactant Dysfunction
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
Jan 9, 2023
Sickle Cell Disease Trial in Chicago (drug, radiation, procedure)
Recruiting
- Sickle Cell Disease
- ATG
- +6 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Oct 21, 2021
Sickle Cell Disease, Sickle Cell Trait Trial in Gainesville (CHOICES, eBook)
Recruiting
- Sickle Cell Disease
- Sickle Cell Trait
- CHOICES
- eBook
-
Gainesville, FloridaUniversity of Florida
May 31, 2022